Federal Circuit reconsiders Teva’s ‘skinny labels’ challenge – Reuters.com

A Federal Circuit U.S. Court of Appeals panel on Tuesday heard arguments for the second time in a potentially far-reaching dispute over Teva Pharmaceuticals USA Inc’s sale of a generic version of GlaxoSmithKline LLC’s heart drug Coreg with a partial label tha…
Read More